日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells

脂质代谢重编程驱动内分泌抗性乳腺癌细胞中的甘油三酯储存和对 FASN 抑制的不同敏感性

Ashley V Ward, Duncan Riley, Kirsten E Cosper, Jessica Finlay-Schultz, Heather M Brechbuhl, Andrew E Libby, Kaitlyn B Hill, Rohan R Varshney, Peter Kabos, Michael C Rudolph #, Carol A Sartorius #

Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer

细胞角蛋白 5 和 17 在基底样乳腺癌中维持侵袭性上皮状态

Olivia McGinn #, Duncan Riley #, Jessica Finlay-Schultz, Kiran V Paul, Peter Kabos, Carol A Sartorius

The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer

雄激素受体是雌激素受体阳性乳腺癌的肿瘤抑制因子

Theresa E Hickey, Luke A Selth, Kee Ming Chia, Geraldine Laven-Law, Heloisa H Milioli, Daniel Roden, Shalini Jindal, Mun Hui, Jessica Finlay-Schultz, Esmaeil Ebrahimie, Stephen N Birrell, Suzan Stelloo, Richard Iggo, Sarah Alexandrou, C Elizabeth Caldon, Tarek M Abdel-Fatah, Ian O Ellis, Wilbert Zwa

Cytokeratin 5 alters β-catenin dynamics in breast cancer cells

细胞角蛋白 5 改变乳腺癌细胞中的 β-catenin 动力学

Olivia McGinn, Ashley V Ward, Lynsey M Fettig, Duncan Riley, Joshua Ivie, Kiran V Paul, Peter Kabos, Jessica Finlay-Schultz, Carol A Sartorius

Fibroblast subtypes define a metastatic matrisome in breast cancer

成纤维细胞亚型定义乳腺癌中的转移性基质体

Heather M Brechbuhl, Alexander S Barrett, Etana Kopin, Jaime C Hagen, Amy L Han, Austin E Gillen, Jessica Finlay-Schultz, Diana M Cittelly, Philip Owens, Kathryn B Horwitz, Carol A Sartorius, Kirk Hansen, Peter Kabos

New generation breast cancer cell lines developed from patient-derived xenografts

从患者来源的异种移植材料开发出的新一代乳腺癌细胞系

Jessica Finlay-Schultz, Britta M Jacobsen, Duncan Riley, Kiran V Paul, Scott Turner, Andrea Ferreira-Gonzalez, J Chuck Harrell, Peter Kabos, Carol A Sartorius

Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III

孕激素受体对乳腺癌的抑制是通过其对雌激素受体和 RNA 聚合酶 III 的调节来实现的

Jessica Finlay-Schultz, Austin E Gillen, Heather M Brechbuhl, Joshua J Ivie, Shawna B Matthews, Britta M Jacobsen, David L Bentley, Peter Kabos, Carol A Sartorius

Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer

细胞角蛋白 5 阳性细胞代表上皮性卵巢癌中的治疗耐药亚群

Bradley R Corr, Jessica Finlay-Schultz, Rachel B Rosen, Lubna Qamar, Miriam D Post, Kian Behbakht, Monique A Spillman, Carol A Sartorius